NEC OncoImmunity AS is an artificial intelligence driven biotech company.
NEC OncoImmunity AS has raised $4.8M in total funding. The most recent round was Seed. The last funding was announced in April 2022.
NEC OncoImmunity AS's investors include Coalition for Epidemic Preparedness Innovations, EISMEA.
NEC OncoImmunity AS is headquartered in Oslo, Norway.
NEC OncoImmunity AS is an artificial intelligence driven biotech company.
NEC OncoImmunity AS is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NEC OncoImmunity AS — Funding & Investors." VCBacked, April 8, 2022, https://www.vcbacked.co/company/nec-oncoimmunity-as. Accessed November 11, 2026.
VCBacked. (2022). NEC OncoImmunity AS — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/nec-oncoimmunity-as
{{cite web |title=NEC OncoImmunity AS — Funding & Investors |url=https://www.vcbacked.co/company/nec-oncoimmunity-as |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at NEC OncoImmunity AS? Request a listing update